LONDON & WILMINGTON, N.C.--(EON: Enhanced Online News)--Chiltern, a leading global contract research organization, is hosting a webinar on “Operational Excellence in Immuno-Oncology Clinical Trials.” The talk will outline ways to manage the complexity of these studies and how to maintain a good relationship with the contract research organization conducting the trial.
“Understanding the complexities of cancer trials is imperative to move therapies like immuno-oncology forward, and we are excited to participate in the type of research that is so intricately designed around the patients.”
During the webinar, the speakers will:
- Examine the complexity of CAR-T studies
- Explore logistics management in a successful CAR-T study
- Review the process for a partnership between the CRO and investigative site
“As new cancer treatments become available, the option to make them personalized to the patient is becoming more common,” said Jim Esinhart, CEO of Chiltern. “Understanding the complexities of cancer trials is imperative to move therapies like immuno-oncology forward, and we are excited to participate in the type of research that is so intricately designed around the patients.”
The webinar will take place Dec. 13 at 10 a.m. (EST). Register at ChilternWebinar.com.
Chiltern, a global contract research organization, is a leading provider of clinical solutions in a variety of specialty areas and engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,200, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance, Strategic Regulatory and Clinical Supplies services using a collaborative approach to maximize efficiency and minimize delays. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.